BIO-TECHNE Corp (TECH) stock
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3040% above fair value
$72.80−0.02 (-0.03%)
Close on Nov 11, 2026Market cap $11.43BP/E 66.8Yield 0.44%
Bio-Techne market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Bio-Techne's market cap was $11.36B on Nov 11, 2026, against $10.05B a year earlier. Over the last 5 years it ranged from $7.59B to $20.32B, with a median of $11.41B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $11.36B | +24.1% |
| 2025 | Dec 31, 2025 | $9.16B | -20.0% |
| 2024 | Dec 31, 2024 | $11.44B | -6.3% |
| 2023 | Dec 29, 2023 | $12.22B | -6.1% |
| 2022 | Dec 30, 2022 | $13.01B | -36.0% |
| 2021 | Dec 31, 2021 | $20.32B | +65.8% |
| 2020 | Dec 31, 2020 | $12.26B | +46.6% |
| 2019 | Dec 31, 2019 | $8.36B | +52.8% |
| 2018 | Dec 31, 2018 | $5.47B | +12.9% |
| 2017 | Dec 29, 2017 | $4.85B | +26.3% |
| 2016 | Dec 30, 2016 | $3.84B | +14.6% |
| 2015 | Dec 31, 2015 | $3.35B | -2.2% |
| 2014 | Dec 31, 2014 | $3.42B | -1.9% |
| 2013 | Dec 31, 2013 | $3.49B | +38.6% |
| 2012 | Dec 31, 2012 | $2.52B | -0.4% |
| 2011 | Dec 30, 2011 | $2.53B | +3.8% |
| 2010 | Dec 31, 2010 | $2.43B | -6.4% |
| 2009 | Dec 31, 2009 | $2.60B | – |
See a number that looks wrong?